Replies to post #9230 on Provectus Biopharmaceuticals Inc (PVCT)

[Mokyo Toe]

I doubt $1 will be on the horizon unless we get Phase III trial data from PV-10. That would do the trick, assuming the data is favorable, but we may be a long way off from seeing it.

Right now, we're struggling to break resistance at .033, and have thusfar been losing the battle.

I'm hoping this little tidbit of news might be enough to inspire enough volume to nudge us back to the .05-.06's again, which is where we were back in March-April.

The current RSI on PVCT is 69.41, just a hair under "overbought", so I wouldn't expect riches this month. But if we can get back to a nickel and hold it, it would be a nice psychological boost.